Cannabigerol, or CBG, is often called the “mother of cannabinoids” because it serves as the precursor from which other major cannabinoids — including CBD and THC — are formed. While naturally found in smaller amounts in most hemp plants, it has become increasingly popular as research continues to explore its unique properties.
 

Early studies suggest CBG may interact with several receptors in the endocannabinoid system, including CB1, CB2, and various TRP channels, which may help explain its potential role in supporting calm, focus, and overall balance. Scientists have also examined CBG in areas related to inflammation, neurological function, and digestive health, though much of this research remains preclinical and ongoing.
 

A 2018 study published in Frontiers in Pharmacology looked at CBG’s activity in neurological models, while other reviews — such as one in Future Medicinal Chemistry — discuss its wide-ranging potential and the growing interest surrounding this lesser-known cannabinoid. These findings are early but promising, helping CBG gain recognition as a valuable complement to other hemp-derived compounds.
 

CBG is commonly available in isolate, broad-spectrum, and full-spectrum forms, and is often used alongside CBD to support clarity, comfort, and overall wellness as part of a holistic cannabinoid routine.